Request Deal Involvement

Patient Square Capital led a $270m Series C funding round in Kriya Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

Canale Communications

pr advisors

Canale Communications

or

Principals

NARYA CAPITAL

bidder

NARYA CAPITAL

PATIENT SQUARE CAPITAL

bidder

PATIENT SQUARE CAPITAL

JDRF

bidder

JDRF

KRIYA THERAPEUTICS INC

target

KRIYA THERAPEUTICS INC

FORESITE CAPITAL MANAGEMENT LLC

bidder

FORESITE CAPITAL MANAGEMENT LLC

QVT FINANCIAL

bidder

QVT FINANCIAL

BLUEBIRD VENTURES

bidder

BLUEBIRD VENTURES

CAM CAPITAL

bidder

CAM CAPITAL

TRANSHUMAN CAPITAL

bidder

TRANSHUMAN CAPITAL

DEXCEL PHARMA

bidder

DEXCEL PHARMA

LIGHTSWITCH CAPITAL

bidder

LIGHTSWITCH CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Patient Square Capital led a $270m Series C funding round in Kriya Therapeutics.